Xenon Pharmaceuticals (XENE) Tops Q4 EPS by 12c

Xenon Pharmaceuticals (NASDAQ: XENE) reported Q4 EPS of ($0.64), $0.12 better than the analyst estimate of ($0.76).

For earnings history and earnings-related data on Xenon Pharmaceuticals (XENE) click here.

You May Also Be Interested In

• Jefferies upgrades Shopify to Buy on AI commerce tailwinds, sees 30% upside
• Landstar System (LSTR) PT Raised to $186 at Stifel
• InMode expects Q2 revenue of $95.2M-$95.4M, full-year up to $375M